2023 Annual Results
Summary of Income Statement and Balance Sheet
Year ended 31 December | |||
(RMB million) | 2023 | 2022 | Better/(Worse) |
---|---|---|---|
Revenue | 27,598 | 25,803 | 7.0% |
Gross Profit | 13,352 | 12,485 | 6.9% |
Selling and distribution expenses | -9,080 | -7,314 | (24.1%) |
Administrative expenses | -1,256 | -1,113 | (12.8%) |
Other income and other gains-net | 524 | 805 | (35.0%) |
Operating Profit | 3,559 | 4,887 | (27.2%) |
EBITDA | 6,157 | 6,542 | 5.9% |
Profit Attributable to Equity Holders | 3,187 | 4,064 | (21.6%) |
Basic Earnings per share (RMB cents) | 123.2 | 155.4 | (20.7%) |
Cash and Cash Equivalents | 5,444 | 7,382 | (26.3%) |
Borrowings | 0 | 0 | N/A |
Net Cash* | 17,976 | 19,050 | (5.6%) |
Current Liabilities | 7,268 | 7,241 | (0.4%) |
Current Ratio (times) | 1.88 | 1.71 | 0.17 |
Total Liabilities to Total Asset Ratio | 28.7% | 27.7% | (1.0p.p) |
- *Net Cash = Cash and Cash Equivalents + Restricted Bank Deposits + Long & Short-term Bank Deposits - Borrowings
Profit Margins and Key Operating Indicators
Year ended 31 December | |||
2023 | 2022 | Better/(Worse) | |
Gross Profit Margin | 48.4% | 48.4% | - |
Operating Profit Margin | 12.9% | 18.9% | (6.0p.p) |
EBITDA Margin | 22.3% | 25.4% | (3.1p.p) |
Margin of Profit Attributable to Equity Holders | 11.5% | 15.7% | (4.2p.p) |
R&D Expenses (as % of revenue) | 2.2% | 2.1% | (0.1p.p) |
A&P Expenses (as % of revenue) | 9.0% | 8.8% | (0.2p.p) |
Staff Costs (as % of revenue) | 8.7% | 7.7% | (1.0p.p) |
Inventory Turnover (Days) | 63 | 58 | (5) |
Trade Receivables Turnover (Days) | 15 | 14 | (1) |
Trade Payables Turnover (Days) | 43 | 42 | 1 |
Cash Conversion Cycle (Days) | 35 | 30 | (5) |
Return on Equity (ROE) | 13.1% | 17.9% | (4.8p.p) |
Return on Asset (ROA) | 9.4% | 12.7% | (3.3p.p) |
CAPEX (RMB million) | 2,024 | 2,176 | 7.0% |
Please download the latest "Acrobat Reader" to view the PDF.